Rudolf Moritz

MicroRNAs in Renal Cell Carcinoma: Diagnostic Implications of Serum miR-1233 Levels

Lena M. Wulfken, Rudolf Moritz, Carsten‐Henning Ohlmann et al. · PLoS ONE · 2011 · 230 citations · Full text

Medicine, Cancer Biology, Oncology +17

Association Between the Number of Dissected Lymph Nodes During Pelvic Lymphadenectomy and Cancer-Specific Survival in Patients with Lymph Node–Negative Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy

Matthias May, Edwin Herrmann, Christian Bolenz et al. · Annals of Surgical Oncology · 2011 · 133 citations

Medicine, Oncology, Surgery +17

Analysis of serum microRNAs (miR-26a-2*, miR-191, miR-337-3p and miR-378) as potential biomarkers in renal cell carcinoma

Stefan Hauser, Lena M. Wulfken, Stefan Holdenrieder et al. · Cancer Epidemiology · 2012 · 101 citations

Medicine, Molecular Medicine, Oncology +16

External Validation of Postoperative Nomograms for Prediction of All-Cause Mortality, Cancer-Specific Mortality, and Recurrence in Patients With Urothelial Carcinoma of the Bladder

Philipp Nuhn, Matthias May, Maxine Sun et al. · European Urology · 2011 · 86 citations

Medicine, Oncology, Urology +14

Analysis of Sex Differences in Cancer-Specific Survival and Perioperative Mortality Following Radical Cystectomy: Results of a Large German Multicenter Study of Nearly 2500 Patients with Urothelial Carcinoma of the Bladder

Wolfgang Otto, Matthias May, Hans‐Martin Fritsche et al. · Gender Medicine · 2012 · 73 citations

Medicine, Surgery, Urology +16